Loading provider…
Loading provider…
Rheumatology Physician in Greenville, NC
NPI: 1740397603Primary Employer
Texas Rheumatology Care
txrheumcare.com
HQ Phone
Get MD Fehmida's Phone Numberphone_androidMobile
Get MD Fehmida's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
CA State Medical License
TX State Medical License
1996 - 2026
CA State Medical License
1995 - 2025

American Board of Internal Medicine
Rheumatology
UPMC Medical Education
Fellowship • Rheumatology
1994 - 1996
Allegheny Health Network Medical Education Consortium (AGH)
Residency • Internal Medicine
1991 - 1994
Dow University of Health Sciences
Medical School
Until 1987
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 164 | 351 |
| 2 | 36415Insertion of needle into vein for collection of blood sample | 150 | 339 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 56 | 56 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 56 | 211 |
| 5 | 96413Infusion of chemotherapy into a vein up to 1 hour | 28 | 156 |
Lead Sponsor: GlaxoSmithKline
Collaborators: Iqvia Pty Ltd
Intervention / Treatment: BIOLOGICAL: Otilimab (GSK3196165), DRUG: csDMARD(s)
Lead Sponsor: GlaxoSmithKline
Collaborators: Iqvia Pty Ltd
Intervention / Treatment: DRUG: csDMARDs, BIOLOGICAL: GSK3196165 (Otilimab), BIOLOGICAL: Sarilumab, DRUG: Placebo to GSK3196165/ Sarilumab
Lead Sponsor: AbbVie
Intervention / Treatment: DRUG: Adalimumab, DRUG: Upadacitinib, DRUG: Adalimumab Matching Placebo, DRUG: Upadacitinib Matching Placebo